  Introduction: Modelling of relative treatment effects is an important aspect
to consider when extrapolating the long-term survival outcomes of treatments.
Flexible parametric models offer the ability to accurately model the observed
data, however, the extrapolated relative treatment effects and subsequent
survival function may lack face validity. Methods: We investigate the ability
of change-point survival models to estimate changes in the relative treatment
effects, specifically treatment delay, loss of treatment effects and converging
hazards. These models are implemented using standard Bayesian statistical
software and propagate the uncertainty associate with all model parameters
including the change-point location. A simulation study was conducted to assess
the predictive performance of these models compared with other parametric
survival models. Change-point survival models were applied to three datasets,
two of which were used in previous health technology assessments. Results:
Change-point survival models typically provided improved extrapolated survival
predictions, particularly when the changes in relative treatment effects are
large. When applied to the real world examples they provided good fit to the
observed data while and in some situations produced more clinically plausible
extrapolations than those generated by flexible spline models. Change-point
models also provided support to a previously implemented modelling approach
which was justified by visual inspection only and not goodness of fit to the
observed data. Conclusions: We believe change-point survival models offer the
ability to flexibly model observed data while also modelling and investigating
clinically plausible scenarios with respect to the relative treatment effects.
